Foreign investments in Danish biotech firms in 2006 up by more than 100%  

2007.06.04
The number of significant foreign investments in Danish biotech companies more than doubled in 2006 compared to the previous year, from 17 to 38, totalling more than DKK 1 bn
The number of significant foreign investments in Danish biotech companies more than doubled in 2006 compared to the previous year, from 17 to 38, totalling more than DKK 1 bn (USD 18 m) and accounting for 50% of investments in the sector. UK's Atlas Venture, Germany's Global Life Science Ventures and Netherlands's Forbion are among the foreign funds and companies investing significantly in Danish biotech companies.
 
Niels Gerner, head of analysis at Medicon Valley Academy, says: "The international funds have started talking about Scandinavia as a strong biotech market. Companies have also delivered the results. They are attractive and have progressed far in their development."
 
Simon Haworth, director of UK's Ipso Ventures comments: "There are some areas of knowledge which we are very interested in. Regarding certain forms of treatment, pure clusters are developing. We are becoming increasingly aware of the opportunities in the Danish biotech sector."
 
The news was reported by national daily newspaper Berlingske Tidende.

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×